BHCM
NEO icon

Brevan Howard Capital Management’s NeoGenomics NEO Stock Holding History

Brevan Howard Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$490K Buy
66,033
+48,458
+276% +$510K ﹤0.01% 1314
2025
Q4 		$207K Buy
+17,575
New +$190K ﹤0.01% 1569
2025
Q3 		– Sell
-28,981
Closed -$212K – 2174
2025
Q2 		$212K Buy
+28,981
New +$234K ﹤0.01% 1692

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Brevan Howard Capital Management's NEO Position: Q1 2026 in Review

Brevan Howard Capital Management increased its NeoGenomics (NEO) stake by 276% in Q1 2026, buying an estimated $510K and bringing the position to 66,033 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.

Brevan Howard Capital Management first reported a position in NEO in Q2 2025 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Brevan Howard Capital Management held 66,033 shares of NeoGenomics worth $490K as of Q1 2026.
  • Brevan Howard Capital Management bought 48,458 NeoGenomics shares in Q1 2026, an estimated $510K.
  • NeoGenomics made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1314 holding.
  • Brevan Howard Capital Management first reported a position in NeoGenomics in Q2 2025 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.